National Health Investors (NHI) to Release Quarterly Earnings on Tuesday

National Health Investors (NYSE:NHI) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, November 5th. Analysts expect National Health Investors to post earnings of $1.12 per share for the quarter. National Health Investors has set its FY24 guidance at $4.52-4.56 EPS and its FY 2024 guidance at 4.520-4.560 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing the consensus estimate of $1.10 by ($0.29). The company had revenue of $84.97 million for the quarter, compared to the consensus estimate of $64.95 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.06 EPS. On average, analysts expect National Health Investors to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

National Health Investors Stock Down 0.3 %

National Health Investors stock opened at $76.45 on Monday. The company’s 50-day moving average price is $80.60 and its two-hundred day moving average price is $72.83. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock has a market cap of $3.32 billion, a P/E ratio of 26.00, a P/E/G ratio of 5.10 and a beta of 1.05. National Health Investors has a twelve month low of $49.25 and a twelve month high of $86.13.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Friday, September 27th were paid a dividend of $0.90 per share. The ex-dividend date was Friday, September 27th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.71%. National Health Investors’s dividend payout ratio (DPR) is currently 122.45%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Truist Financial boosted their target price on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Bank of America assumed coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target on the stock. Finally, Wells Fargo & Company downgraded shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price objective for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.